These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32548875)

  • 1. Bias in case-crossover studies of medications due to persistent use: A simulation study.
    Bykov K; Wang SV; Hallas J; Pottegård A; Maclure M; Gagne JJ
    Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1079-1085. PubMed ID: 32548875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent User Bias in Case-Crossover Studies in Pharmacoepidemiology.
    Hallas J; Pottegård A; Wang S; Schneeweiss S; Gagne JJ
    Am J Epidemiol; 2016 Nov; 184(10):761-769. PubMed ID: 27780801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future cases as present controls to adjust for exposure trend bias in case-only studies.
    Wang S; Linkletter C; Maclure M; Dore D; Mor V; Buka S; Wellenius GA
    Epidemiology; 2011 Jul; 22(4):568-74. PubMed ID: 21577117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel weighting method to remove bias from within-subject exposure dependency in case-crossover studies.
    Kubota K; Kelly TL; Sato T; Pratt N; Roughead E; Yamaguchi T
    BMC Med Res Methodol; 2021 Oct; 21(1):214. PubMed ID: 34657592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of estimators from self-controlled case series, case-crossover design, and sequence symmetry analysis for pharmacoepidemiological studies.
    Takeuchi Y; Shinozaki T; Matsuyama Y
    BMC Med Res Methodol; 2018 Jan; 18(1):4. PubMed ID: 29310575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "First-wave" bias when conducting active safety monitoring of newly marketed medications with outcome-indexed self-controlled designs.
    Wang SV; Schneeweiss S; Maclure M; Gagne JJ
    Am J Epidemiol; 2014 Sep; 180(6):636-44. PubMed ID: 25086050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left truncation results in substantial bias of the relation between time-dependent exposures and adverse events.
    Hazelbag CM; Klungel OH; van Staa TP; de Boer A; Groenwold RH
    Ann Epidemiol; 2015 Aug; 25(8):590-6. PubMed ID: 25935711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Different Case-Crossover Variants in Handling Exposure-Time Trend or Persistent-User Bias: Using Dipeptidyl Peptidase-4 Inhibitors and the Risk of Heart Failure as an Example.
    Dong YH; Wang SV; Gagne JJ; Wu LC; Chang CH
    Value Health; 2020 Feb; 23(2):217-226. PubMed ID: 32113627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of instrumental variable methods in cohort and nested case-control studies: a simulation study.
    Uddin MJ; Groenwold RH; de Boer A; Belitser SV; Roes KC; Hoes AW; Klungel OH
    Pharmacoepidemiol Drug Saf; 2014 Feb; 23(2):165-77. PubMed ID: 24306965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of case-time-control design in pharmacovigilance applications: exploration with high-risk medications and unplanned hospital admissions in the Western Australian elderly.
    Price SD; Holman CD; Sanfilippo FM; Emery JD
    Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1159-70. PubMed ID: 23797984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods for time-varying exposure related problems in pharmacoepidemiology: An overview.
    Pazzagli L; Linder M; Zhang M; Vago E; Stang P; Myers D; Andersen M; Bahmanyar S
    Pharmacoepidemiol Drug Saf; 2018 Feb; 27(2):148-160. PubMed ID: 29285840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of prior event rate ratio adjustment method in pharmacoepidemiology: a simulation study.
    Uddin MJ; Groenwold RH; van Staa TP; de Boer A; Belitser SV; Hoes AW; Roes KC; Klungel OH
    Pharmacoepidemiol Drug Saf; 2015 May; 24(5):468-77. PubMed ID: 25410590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case-crossover analyses of air pollution exposure data: referent selection strategies and their implications for bias.
    Janes H; Sheppard L; Lumley T
    Epidemiology; 2005 Nov; 16(6):717-26. PubMed ID: 16222160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An approach to checking case-crossover analyses based on equivalence with time-series methods.
    Lu Y; Symons JM; Geyh AS; Zeger SL
    Epidemiology; 2008 Mar; 19(2):169-75. PubMed ID: 18223483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When should case-only designs be used for safety monitoring of medical products?
    Maclure M; Fireman B; Nelson JC; Hua W; Shoaibi A; Paredes A; Madigan D
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():50-61. PubMed ID: 22262593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case-crossover study design in pharmacoepidemiology: systematic review and recommendations.
    Consiglio GP; Burden AM; Maclure M; McCarthy L; Cadarette SM
    Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1146-53. PubMed ID: 24030723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of short-term exposure to air pollution on hospital admissions of young children for acute lower respiratory infections in Ho Chi Minh City, Vietnam.
    ; Le TG; Ngo L; Mehta S; Do VD; Thach TQ; Vu XD; Nguyen DT; Cohen A
    Res Rep Health Eff Inst; 2012 Jun; (169):5-72; discussion 73-83. PubMed ID: 22849236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bias Due to Within-Subject Exposure Dependency With or Without Bias Due to Lack of Pairwise Exchangeability When Exposure Is Chronic in Case-Crossover and Case-Time-Control Studies: A Simulation Study.
    Kubota K; Kelly TL
    Am J Epidemiol; 2023 Oct; 192(10):1701-1711. PubMed ID: 37083936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential for bias in case-crossover studies with shared exposures analyzed using SAS.
    Wang SV; Coull BA; Schwartz J; Mittleman MA; Wellenius GA
    Am J Epidemiol; 2011 Jul; 174(1):118-24. PubMed ID: 21540322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Within-subject exposure dependency in case-crossover studies.
    Vines SK; Farrington CP
    Stat Med; 2001 Oct; 20(20):3039-49. PubMed ID: 11590631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.